RWE Portfolio Ontada's ON.Journey launches a portfolio of off-the-shelf longitudinal oncology datasets, presenting a licensing or subscription opportunity to pharma, CROs, and academia with potential for customized studies and post-market evidence generation.

EHR Integrations Leveraging iKnowMed EHR data and the Trinity Partners integration, there is an opportunity to expand to additional EHR sources and healthcare systems to enable richer, multi-source oncology analytics for customers.

Provider Partnerships The integration of Florida Cancer Specialists & Research Institute data showcases a scalable provider network model, enabling partnerships with more cancer centers for data-sharing, joint real-world evidence programs, and co-developed studies.

Pharma Collaborations Existing collaborations with Caris Life Sciences and other partners indicate strong demand for pharma-grade analytics and AI-driven insights, creating a path to offer real-world evidence, molecular profiling data, and clinical education solutions to drug developers and life sciences firms.

Compliance Advantage GDPR compliance and robust data governance capabilities position Ontada as a secure partner for global oncology research, a differentiator for multinational studies requiring privacy controls, consent management, and audit-ready data.